Skip to Content

Catalyst/MAP Global Balanced A TRXAX

Medalist Rating as of | See Catalyst Investment Hub
  • NAV / 1-Day Return 11.31  /  −0.09 %
  • Total Assets 14.9 Mil
  • Adj. Expense Ratio
    1.230%
  • Expense Ratio 1.230%
  • Distribution Fee Level Above Average
  • Share Class Type Front Load
  • Category Global Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity
  • Status Open
  • TTM Yield 2.86%
  • Turnover 36%

USD | NAV as of Apr 24, 2024 | 1-Day Return as of Apr 24, 2024, 10:23 PM GMT+0

Morningstar’s Analysis TRXAX

Will TRXAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Catalyst/ MAP Global Balanced A's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TRXAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 25.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

United States Treasury Notes 0.375%

6.44 975,260
Government

Microsoft Corp

3.16 479,451
Technology

Thai Beverage PLC

2.75 416,926
Consumer Defensive

Nestle SA ADR

2.70 408,521
Consumer Defensive

Vivendi SE

2.66 402,722
Communication Services

United States Treasury Notes 2.5%

2.61 395,587
Government

Sanofi SA ADR

2.47 374,367
Healthcare

Takeda Pharmaceutical Co Ltd ADR

2.45 371,020
Healthcare

Bunge Global SA

2.33 353,527
Consumer Defensive

Imperial Brands PLC ADR

2.31 349,650
Consumer Defensive